Stock Quote

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Signify Health, Inc. (NYSE - SGFY)

BALA CYNWYD, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Signify Health, Inc. (“Signify Health” or the “Company”) (NYSE – SGFY) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to be acquired by CVS Health® (NYSE - CVS). Under the terms of the merger agreement, Signify Health shareholders will receive $30.50 in cash for each share of the Company they own, representing a total transaction value of approximately $8 billion.

The investigation concerns whether the Signify Health Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether CVS Health® is paying too little for the Company.

If you own shares of Signify Health stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/signify-health-inc-nyse-sgfy/, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.